Product Name:1-(oxan-2-yl)-1H-pyrazole

IUPAC Name:1-(oxan-2-yl)-1H-pyrazole

CAS:449758-17-2
Molecular Formula:C8H12N2O
Purity:98%+
Catalog Number:CM104631
Molecular Weight:152.2

Packing Unit Available Stock Price($) Quantity
CM104631-100g in stock ħř
CM104631-500g in stock ǎŌŌ

For R&D use only.

Inquiry Form

   refresh    

Product Details

CAS NO:449758-17-2
Molecular Formula:C8H12N2O
Melting Point:-
Smiles Code:C1CCC(OC1)N1C=CC=N1
Density:
Catalog Number:CM104631
Molecular Weight:152.2
Boiling Point:269.7°C at 760 mmHg
MDL No:MFCD11044692
Storage:2-8°C

Category Infos

Pyrazoles
Pyrazoles are organic compounds of the general formula C3H3N2H. It is a five-membered heterocycle consisting of three carbon atoms and two adjacent nitrogen atoms. As an H-bond-donating heterocycle, pyrazole has been used as a more lipophilic and metabolically more stable bioisomer of phenol. Pyrazoles have attracted more and more attention due to their broad spectrum of action and strong efficacy.
Pyrazone
Custom pyrazone for customers from all over the world are our main business.
Tetrahydropyrans
Tetrahydropyran is an organic compound consisting of a saturated six-membered ring containing five carbon atoms and one oxygen atom. Tetrahydropyrans are common structural motifs in natural products and synthetic therapeutic molecules. In nature, these six-membered oxygen heterocycles are usually assembled by intramolecular reactions, including oxygen Michael addition or ring opening of epoxy alcohols. In fact, polyether natural products have been particularly extensively studied for their fascinating structures and important biological properties; these are often formed through endoselective epoxy open cascades.

Column Infos

Pyrans
Pyrans are an important class of six-membered heterocyclic compounds, non-aromatic rings, composed of five carbon atoms and one oxygen atom, and contain two double bonds. The molecular formula of pyran is C5H6O, and there are two isomers. Pyrans, together with benzo derivatives, form scaffolds for a variety of drug applications, many of which are approved and promising candidates in clinical trials and recently isolated bioactive natural products.